Anavex Life Sciences Corp.盘中异动急速下挫5.62%报6.21美元

自选股智能写手08-02

北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-12.42倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2456281246?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-02 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2456281246","market":"us","top_or_hot":-1,"title":"Anavex Life Sciences Corp.盘中异动 急速下挫5.62%报6.21美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-12.42倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anavex Life Sciences Corp.盘中异动 急速下挫5.62%报6.21美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnavex Life Sciences Corp.盘中异动 急速下挫5.62%报6.21美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-02 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-12.42倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVXL","symbol_name":"Anavex Life Sciences Corp.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b","article_id":"2456281246","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213024af95a53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2456281246","pubTimestamp":1722605423,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.92%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AVXL":"Anavex Life Sciences Corp.","BK4139":"生物科技"},"translate_title":"Anavex Life Sciences Corp. fell 5.62% to $6.21 after intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVXL":1},"content_text":"北京时间2024年08月02日21时30分，Anavex Life Sciences Corp.（AVXL.us）股票出现异动，股价大幅下跌5.62%。截至发稿，该股报6.21美元/股，成交量2.062万股，换手率0.02%，振幅1.52%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.55百万美元，每股收益-0.13美元，毛利0.00美元，市盈率-12.42倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 (To Pur Com)、Moleculin Biotech, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为213.34%、37.43%、14.12%，振幅较大的相关个股有Xencor, Inc.、Adaptimmune Therapeutics Plc、Trevena, Inc.，振幅分别为8.12%、3.93%、3.27%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过将精准医学应用于具有高度未满足需求的中枢神经系统疾病来开发差异化疗法。该公司分析来自临床研究的基因组数据以识别生物标志物，这些生物标志物用于选择将获得治疗神经退行性和神经发育疾病治疗益处的患者。 其先导化合物 ANAVEX 2-73 正在开发中，用于治疗阿尔茨海默病、帕金森病和潜在的其他中枢神经系统疾病，包括Rett 综合征（一种罕见的严重神经单基因疾病）等罕见疾病。 该公司的运营部门致力于开发治疗中枢神经系统疾病的新疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2456281246"}

Anavex Life Sciences Corp.盘中异动 急速下挫5.62%报6.21美元

精彩评论

Anavex Life Sciences Corp.盘中异动急速下挫5.62%报6.21美元